30 associations analyzed non-repeated outcomes, including nine (30%) cardiovascular and mortality events, six (20%) lipid profile outcomes, nine (30%) glucose-insulin homeostasis outcomes, two (6.7%) blood pressure outcomes, two (6.7%) body weight outcomes, one outcome (3.3%) of quality of life, and another (3.3%) with a diagnosis of cancer. The gene discussed is INS; the disease is cancer.